What is Nebulizers Market?
Nebulizers are tools that help for taking asthma medicines, it may be easier to use especially for children who aren’t old enough to properly use inhalers, or adults with severe asthma. Nebulizers turn liquid medicine into a mist and delivers it directly to the lungs. The nebulizers are available in electric and battery run version. It have a base that holds an air compressor, a small container for liquid medicine and a tube that connects the air compressor to the medicine container.
The market study is being classified by Type (Jet or Pneumatic [Breath-Actuated, Vented], Ultrasonic [Portable, Stand Alone] and Mesh [Static Mesh, Vibrating]), by Application (Home, Hospitals and Clinics and Physician) and major geographies with country level break-up.
DeVilbiss Healthcare (United States), Rossmax International Ltd. (Taiwan), OMRON Corporation (Japan), PARI Pharma GmbH (Germany), Allied Healthcare Products Inc. (United States), Agilent Technologies (United States), Philips Healthcare (Netherlands), Airssential (Australia), Clement Clarke International (United Kingdom), Briggs Healthcare (United States) and Medline Industries, Inc. (United States) are some of the key players profiled in the study.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined collaborations.
Segment Analysis
Analyst at AMA have segmented the market study of Global Nebulizers market by Type, Application and Region.
On the basis of geography, the market of Nebulizers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Growing Need to Control Healthcare Expenditure
- Rising Incidence of Chronic Respiratory Diseases
Market Trend
- Increasing Adoption of Home Healthcare Devices
- Availability of Alternatives such as Metered-Dose-Inhaler (MDI)
Restraints
- Dispersion and Wastage of the Drug during Delivery to the Respiratory Tract
Opportunities
- Technology advancement in Nebulizers
Challenges
- Delivery of medications takes longer through a nebulizer than through an inhaler
- Often require a stationary power source.
Market Leaders and some development strategies
July 2, 2018: OMRON Healthcare Announces Acquisition of 3A Health Care S.R.L. With this acquisition we are gaining strong talent and innovative technology that builds on our R&D and production expertise. It will allow us to provide a broader portfolio of respiratory. and November 2, 2018: Briggs Healthcare acquires Selman-Holman & Associates to expand home health compliance portfolio as a wholly owned subsidiary of Briggs, Selman-Holman will continue to expand its education and compliance solutions for the home health industry.
Ordinarily, an application supporting the approval of a new nebulizer would be reviewed by the Center for Devices and Radiologic Health (CDRH) under section 510(k) of the Food, Drug, and Cosmetics Act, under which a nebulizer is a class II device.
Key Target Audience
Manufacturers of Nebulizers, Suppliers of Nebulizers, Wholesalers, Distributers and Retailers of Nebulizers, Healthcare Industry, Research Firms and Governmental Bodies